JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

A8696 FIIN-2

Target: FGFR

Summary: Irreversible inhibitor of FGFR

≥31.75 mg/mL
B3232 Z-IETD-FMK

12 Citation

Target: Caspases

Summary: Caspase-8 inhibitor

≥32.73 mg/mL
A1901 Q-VD-OPh

53 Citation

Target: Caspases

Summary: Cell-permeable, irreversible pan-caspase inhibitor

≥25.67 mg/mL
A1904 Boc-D-FMK

1 Citation

Target: Caspases

Summary: Pan-caspase inhibitor

insoluble in H2O; ≥11.65 mg/mL
A1920 Z-DEVD-FMK

12 Citation

Target: Caspases

Summary: Caspase-3 inhibitor

insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
B3233 Z-LEHD-FMK

8 Citation

Target: Caspases

Summary: Irreversible Caspase-9 inhibitor.

insoluble in H2O; ≥107.4 mg/mL
A8170 Z-FA-FMK

Target: cysteine protease

Summary: Cysteine proteases inhibitor

insoluble in H2O; ≥13.45 mg/mL
A8247 Afatinib (BIBW2992)

1 Citation

Target: EGFR

Summary: Irreversible EGFR/HER2 inhibitor

≥24.3 mg/mL
A4010 Salinosporamide A (NPI-0052, Marizomib)

Target: Proteasome

Summary: 20S proteasome inhibitor

Soluble in DMSO
A8202 Abiraterone acetate

Target: Cytochrome P450 (CYP450)

Summary: Cytochrome p450 17a1 inhibitor

insoluble in H2O; ≥11.22 mg/mL